Genxone (WAR:GX1) Days Payable : 30.83 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Genxone Days Payable?

Genxone's average Accounts Payable for the three months ended in Mar. 2024 was zł0.09 Mil. Genxone's Cost of Goods Sold for the three months ended in Mar. 2024 was zł0.26 Mil. Hence, Genxone's Days Payable for the three months ended in Mar. 2024 was 30.83.

The historical rank and industry rank for Genxone's Days Payable or its related term are showing as below:

WAR:GX1' s Days Payable Range Over the Past 10 Years
Min: 26.35 Med: 32.26 Max: 4691.15
Current: 29.04

During the past 6 years, Genxone's highest Days Payable was 4691.15. The lowest was 26.35. And the median was 32.26.

WAR:GX1's Days Payable is ranked worse than
83.52% of 722 companies
in the Biotechnology industry
Industry Median: 148.145 vs WAR:GX1: 29.04

Genxone's Days Payable declined from Mar. 2023 (39.25) to Mar. 2024 (30.83). It may suggest that Genxone accelerated paying its suppliers.

Genxone Days Payable Historical Data

The historical data trend for Genxone's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genxone Days Payable Chart

Genxone Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

704.86

29.81

26.66

26.35

34.71

Genxone Quarterly Data
	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Payable	Get a 7-Day Free Trial															39.25	24.43	31.37	36.36	30.83

Competitive Comparison of Genxone's Days Payable

For the Biotechnology subindustry, Genxone's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genxone's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genxone's Days Payable distribution charts can be found below:

* The bar in red indicates where Genxone's Days Payable falls into.

Genxone Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Genxone's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.25	+	0.092)	/	2 )	/	1.798	*	365
=	0.171					/	1.798	*	365
=	34.71

Genxone's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

	Days Payable (Q: Mar. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (0.092	+	0.083)	/	2 )	/	0.259	*	365 / 4
=	0.0875					/	0.259	*	365 / 4
=	30.83

Genxone Days Payable Related Terms

Thank you for viewing the detailed overview of Genxone's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Genxone (WAR:GX1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genxone SA (WAR:GX1) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Kobaltowa 6, Zlotniki, Suchy Las, POL, 62-002

Website

https://www.genxone.eu

Genxone SA is a biotechnology company that applies nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. It specializes in developing new products and solutions based on the latest technologies of nucleic acid sequencing. The company's services include NANOPORE SEQUENCING that includes Whole Genome Sequencing, Bespoke Analysis, Metagenome Sequencing, Bioinformatic Analysis, 16S and/or ITS Gene Sequencing, and RNA Sequencing; and DIAGNOSTIC TESTS that includes Gastrointestinal Infections Panel, Respiratory Infections Panel, Urogenital Infection Panel, and Nervous System Infection Panel.

Genxone (WAR:GX1) Headlines

No Headlines